Cell Reports (Dec 2023)

PIM kinases regulate early human Th17 cell differentiation

  • Tanja Buchacher,
  • Ankitha Shetty,
  • Saara A. Koskela,
  • Johannes Smolander,
  • Riina Kaukonen,
  • António G.G. Sousa,
  • Sini Junttila,
  • Asta Laiho,
  • Olof Rundquist,
  • Tapio Lönnberg,
  • Alexander Marson,
  • Omid Rasool,
  • Laura L. Elo,
  • Riitta Lahesmaa

Journal volume & issue
Vol. 42, no. 12
p. 113469

Abstract

Read online

Summary: The serine/threonine-specific Moloney murine leukemia virus (PIM) kinase family (i.e., PIM1, PIM2, and PIM3) has been extensively studied in tumorigenesis. PIM kinases are downstream of several cytokine signaling pathways that drive immune-mediated diseases. Uncontrolled T helper 17 (Th17) cell activation has been associated with the pathogenesis of autoimmunity. However, the detailed molecular function of PIMs in human Th17 cell regulation has yet to be studied. In the present study, we comprehensively investigated how the three PIMs simultaneously alter transcriptional gene regulation during early human Th17 cell differentiation. By combining PIM triple knockdown with bulk and scRNA-seq approaches, we found that PIM deficiency promotes the early expression of key Th17-related genes while suppressing Th1-lineage genes. Further, PIMs modulate Th cell signaling, potentially via STAT1 and STAT3. Overall, our study highlights the inhibitory role of PIMs in human Th17 cell differentiation, thereby suggesting their association with autoimmune phenotypes.

Keywords